參考文獻/References:
[1] 中國醫(yī)師協(xié)會骨科醫(yī)師分會骨循環(huán)與骨壞死專業(yè)委員會,中華醫(yī)學(xué)會骨科分會骨顯微修復(fù)學(xué)組,國際骨循環(huán)學(xué)會中國區(qū).中國成人股骨頭壞死臨床診療指南(2020)[J].中華骨科雜志,2020,40(20):1356-1376.
[2] 余華晨.淫羊藿苷干預(yù)骨微血管內(nèi)皮細胞防治激素性股骨頭壞死的實驗研究[D].北京:北京協(xié)和醫(yī)學(xué)院,2020.
[3] KONARSKI W,POBOZY T,SLIWCZY?SKI A,et al.Avascular necrosis of femoral head-overview and current state of the Art[J].Int J Environ Res Public Health,2022,19(12):7348.
[4] HU K,SHANG Z,YANG X,et al.Macrophage polarization and the regulation of bone immunity in bone homeostasis[J].J Inflamm Res,2023,16:3563-3580.
[5] JIN T,ZHANG Y,SUN Y,et al.IL-4 gene polymorphisms and their relation to steroid-induced osteonecrosis of the femoral head in Chinese population[J].Mol Genet Genomic Med,2019,7(3):e563.
[6] WU X,FENG X,HE Y,et al.IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-alpha-induced apoptosis in steroid-induced osteonecrosis[J].Osteoporos Int,2016,27(5):1827-1837.
[7] MA J,GE J,GAO F,et al.The role of immune regulatory cells in nontraumatic osteonecrosis of the femoral head:a retrospective clinical study[J].Biomed Res Int,2019,2019:1302015.
[8] RON S,YARDEN W,YOAV N,et al.The total mass,number,and distribution of immune cells in the human body[J/OL].Proc Nati Acad Sci U S A,2023,120(44):e2308511120[2023-11-03].https://pubmed.ncbi.nlm.nih.gov/37871201/.
[9] 吳亞洲,陳威,趙海燕,等.骨骼疾病巨噬細胞與破骨細胞交互作用的研究進展[J].中國矯形外科雜志,2023,31(19):1778-1782.
[10] 劉從瑤,葛冰磊,俞善春,等.老年骨肉瘤患者外周血血管內(nèi)皮生長因子、半乳糖凝集素3、T淋巴細胞亞群和血管生成素-2表達水平及其臨床意義分析[J].中國醫(yī)學(xué)前沿雜志(電子版),2021,13(4):106-110.
[11] 程征,李可大,宋夢,等.基于TGF-β/BMP/Smad信號通路治療激素性股骨頭壞死的中醫(yī)藥研究進展[J/OL].遼寧中醫(yī)藥大學(xué)學(xué)報,2023[2023-11-03].https://link.cnki.net/urlid/21.1543.R.20230913.1248.004.
[12] 陳要臻.骨相關(guān)間充質(zhì)基質(zhì)細胞中NLRP3和Caspase-11炎癥小體功能的研究[D].西安:空軍軍醫(yī)大學(xué),2019.
[13] 王亞東.骨髓間充質(zhì)干細胞外泌體對創(chuàng)傷性顱腦損傷后神經(jīng)炎癥的影響及其機制研究[D].杭州:浙江大學(xué),2021.
[14] RAMIREZ-VELAZQUEZ C,PAREDES-PALMA J C,PATZI-VARGAS S V.Natural killer T cells:a powerful via in the regulation of non communicable chronic diseases[J].Clin Med Res,2019,8(6):137.
[15] ROSSHIRT N,TRAUTH R,PLATZER H,et al.Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis[J].Arthritis Res Ther,2021,23(1):37.
[16] 郭曹培,程飄濤,楊成兵,等.骨免疫與骨代謝[J].中國組織工程研究,2024,28(14):2261-2266.
[17] CHEN C,ZHAO X,LUO Y,et al.Imbalanced T-cell subsets may facilitate the occurrence of osteonecrosis of the femoral head[J].J Inflamm Res,2022,15:4159-4169.
[18] ZHU J,PAUL W E.CD4 T cells:fates,functions,and faults[J].Blood,2008,112(5):1557-1569.
[19] GONZ?LEZ-OSUNA L,SIERRA-CRISTANCHO A,ROJAS C,et al.Premature senescence of T-cells favors bone loss during osteolytic diseases.A new concern in the osteoimmunology arena[J].Aging Dis,2021,12(5):1150-1161.
[20] LONCAR S R,HALCROW S E,SWALES D.Osteoimmunology:the effect of autoimmunity on fracture healing and skeletal analysis[J].Forensic Sci Int Synerg,2023,6:100326.
[21] 郭英俊.Th17及其相關(guān)細胞因子在股骨頭壞死所致的疼痛中的重要意義[D].濟南:山東大學(xué),2016.
[22] 吳元勝,馬茂瀟,朱英杰,等.Th17/Treg在骨科疾病中的研究進展[J].中國骨質(zhì)疏松雜志,2023,29(5):713-718.
[23] LUCCA L E,DOMINGUEZ-VILLAR M.Modulation of regulatory T cell function and stability by co-inhibitory receptors[J].Nat Rev Immunol,2020,20(11):680-693.
[24] 王本杰.股骨頭壞死多模態(tài)影像與病理對照及治療研究[D].大連:大連理工大學(xué),2016.
[25] ZOU D,ZHANG K,YANG Y,et al.Th17 and IL-17 exhibit higher levels in osteonecrosis of the femoral head and have a positive correlation with severity of pain[J].Endokrynol Pol,2018,69(3):283-290.
[26] 蔡李駿,王秋入,陳長軍,等.免疫細胞調(diào)節(jié)股骨頭壞死發(fā)生發(fā)展的研究進展[J].中國修復(fù)重建外科雜志,2022,36(11):1428-1433.
[27] MISHRA S,SRINIVASAN S,MA C,et al.CD8+ regulatory T cell-A mystery to be revealed[J].Front Immunol,2021,12:708874.
[28] 丁柳,石彬,白冰.γδT淋巴細胞及其受體多樣性的研究進展[J].細胞與分子免疫學(xué)雜志,2020,36(7):645-650.
[29] HU Z,ZOU Q,SU B.Regulation of T cell immunity by cellular metabolism[J].Front Med,2018,12(4):463-472.
[30] LIU T,ZHENG X,WANG C,et al.The m6A “reader” YTHDF1 promotes osteogenesis of bone marrow mesenchymal stem cells through translational control of ZNF839[J].Cell Death Dis,2021,12(11):1078.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):20.